The tumour immune microenvironment in mucosal melanomas also shows reduced immune cell infiltration and a weaker interferon-gamma signature compared with cutaneous melanoma—a difference that is especially marked in urogenital tumours compared with those of the head and neck [21] (See Figure 1). The gene discussed is IFNG; the disease is cutaneous melanoma.